| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.34 | 0.04 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |